Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

2(40.0%)

Phase 1

2(40.0%)

N/A

1(20.0%)

5Total

Phase 2(2)

Phase 1(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT00797420Phase 1Completed

Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and Toddlers

Role: collaborator

NCT00491426Completed

Antimicrobial PK in Infants With Suspected or Confirmed Infection

Role: collaborator

NCT00514358Completed

Fluconazole Pharmacokinetics in Infants

Role: collaborator

NCT00166634Not ApplicableCompleted

Ambulatory Blood Pressure Monitoring in Hypertension

Role: collaborator

NCT00491790Phase 2Unknown

Montelukast With Status Asthmaticus, Ages 2-5

Role: collaborator

NCT00494572Phase 2Unknown

Montelukast With Status Asthmaticus, Ages 6-18

Role: collaborator

NCT00760279Phase 1Completed

An Open Label Evaluation of the Pharmacokinetics and Safety of Single Dose Intravenous Azithromycin in Preterm Neonates

Role: collaborator

All 7 trials loaded